Benzinga | Jul 7, 2021 08:36AM EDT

ReShape Lifescience Highlights Completion Of Lap-Band Manufacturing Transition To Massachusetts-Based Manufacturer

ReShape Lifesciences Inc. (NASDAQ:RSLS), the premier physician-led weight loss and metabolic health-solutions company, today announced it has completed their Lap-Band(r) manufacturing transition from Apollo Endosurgery, Inc to a Massachusetts-based manufacturer. ReShape Lifesciences(tm) expects this change to enable it to reduce costs, improve margins and directly control the manufacturing process.

The Lap-Band, now manufactured by ReShape Lifesciences, is the only FDA-approved, laparoscopic weight-loss device specifically indicated for a BMI of 30 or higher in the U.S. The procedure has been performed worldwide over one million times since 1993 and is reimbursed for eligible patients by most insurance companies. The Lap-Band is proven to be the safest bariatric procedure available on the market,[i] backed by 20 years of clinical data demonstrating lower complication and mortality rates compared to other surgical weight-loss procedures.

"Moving Lap-Band production under our direct operations allows us to have better control of the manufacturing process for significant cost reductions, anticipated scale and improved efficiencies," commented Bart Bandy, President and Chief Executive Officer at ReShape Lifesciences. "As we all emerge from the recent pandemic, we are proud to provide products that are able to help a growing population of people with weight-loss needs and to support the addition of new manufacturing and logistics jobs in the United States."